NEW YORK (GenomeWeb News) – Crescendo Bioscience today announced the completion of a $28 million Series D financing round led by Skyline Ventures and Safeguard Scientifics.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.
The New York Stem Cell Foundation signs a lease for a new space.
Researchers gear up for an international meeting to discuss the ethics of gene editing.
The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.